Shopping Cart
- Remove All
Your shopping cart is currently empty
IMAB027 (ASP1650) is a selective monoclonal antibody against CLDN6 (Claudin 6) with antitumor activity that induces death of CLDN6+ cancer cells through antibody-dependent and complement-dependent cytotoxicity.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $298 | In Stock | |
| 5 mg | $723 | In Stock | |
| 10 mg | $975 | In Stock | |
| 25 mg | $1,430 | In Stock | |
| 50 mg | $1,950 | In Stock |
| Description | IMAB027 (ASP1650) is a selective monoclonal antibody against CLDN6 (Claudin 6) with antitumor activity that induces death of CLDN6+ cancer cells through antibody-dependent and complement-dependent cytotoxicity. |
| In vitro | IMAB027 selectively binds to CLDN6 but not to its closely related family members such as Claudins 3, 4 and 9. In CLDN6+-expressing ovarian and testicular cancer cell lines, IMAB027 was able to induce selective antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in target cells. [1] |
| In vivo | IMAB027 inhibited tumor growth and improved overall survival in mice transplanted with human CLDN6+ cells. [1] |
| Synonyms | IMAB 027, ASP-1650, ASP1650, ASP 1650 |
| Cas No. | 1650599-68-0 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.